91˿Ƶ

News

91˿Ƶ joins Moderna in battle against global health threats

Published: 25 March 2022

91˿Ƶ has joined Moderna’s program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. 91˿Ƶ is the first university in Canada to join this program as it ramps up its international rollout.

“This partnership is a sign of 91˿Ƶ’s strength in core research that changes lives,” said Martha Crago, Vice-Principal, Research & Innovation. “We are an acknowledged leader in mRNA, and joining this platform will help us develop vaccines that will protect human health everywhere on the planet.”

“Moderna’s goal is to create a global community of scientists who leverage our mRNA vaccine technology to develop innovative approaches to address emerging and neglected infectious diseases that pose a risk to public health,” said Hamilton Bennett BSc(FSc)’07, Senior Director of Vaccine Access and Partnerships, Moderna. “We look forward to working with 91˿Ƶ and our other global partners to prevent future pandemics and help millions of people around the world.”

The full article is available in the .

Back to top